Renaissance Technologies (RenTech)'s LUCD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 71,300 shares of Lucid Diagnostics Inc. (LUCD) worth $76,291, representing 0.00% of the portfolio. First purchased in 2021-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in LUCD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 532,894 shares. Largest reduction occurred in Q2 2026, reducing 428,361 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Lucid Diagnostics (LUCD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lucid Diagnostics (LUCD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -428,361 | Reduce 85.73% | 71,300 | $1.07 |
| Q1 2026 | -326,866 | Reduce 39.55% | 499,661 | $1.15 |
| Q4 2025 | +532,894 | Add 181.48% | 826,527 | $1.09 |
| Q3 2025 | +50,354 | Add 20.70% | 293,633 | $1.01 |
| Q2 2025 | -215,786 | Reduce 47.01% | 243,279 | $1.15 |
| Q1 2025 | +459,065 | New Buy | 459,065 | $1.49 |
| Q1 2022 | -20,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | +20,000 | New Buy | 20,000 | $5.35 |
Renaissance Technologies (RenTech)'s Lucid Diagnostics Investment FAQs
Renaissance Technologies (RenTech) first purchased Lucid Diagnostics Inc. (LUCD) in Q4 2021, acquiring 20,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Lucid Diagnostics Inc. (LUCD) for 8 quarters since Q4 2021.
Renaissance Technologies (RenTech)'s largest addition to Lucid Diagnostics Inc. (LUCD) was in Q4 2025, adding 826,527 shares worth $900,914.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 71,300 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $76,291.
As of the Q2 2026 filing, Lucid Diagnostics Inc. (LUCD) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Lucid Diagnostics Inc. (LUCD) was 826,527 shares, as reported at the end of Q4 2025.